Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04876599 · ClinicalTrials.gov registry record · NA
Mind-body Resiliency Intervention for Fear of Cancer Recurrence
A NA study of Cancer and Coping Skills, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 5
- Study locations
NCT04876599: Completed NA study of Cancer and Coping Skills, sponsored by Massachusetts General Hospital.
NCT04876599 is a NA study of Cancer and Coping Skills that has completed, run by Massachusetts General Hospital. The registered enrollment target is 64 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04876599, a NA study of Cancer and Coping Skills, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.
Primary Outcome
The primary metric for assessing feasibility will be retention at the initial follow-up assessment (≥70% survey completion). For descriptive purposes, secondary exploratory metrics of feasibility will include reasons for ineligibility, refusal, or dropping out will be measured, as will rates of enrollment, ratio of screened-to-eligible, attendance (e.g., ≥75% of intervention sessions attended), self-reported adherence to relaxation skills practice, and interventionist fidelity. Exit interviews w
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL IN FOCUS
Study Locations (5)
Massachusetts
- Massachusett General Hospital Cancer Center - Boston
- Beth Israel Deaconess Medical Center - Boston
- Mass General at Emerson Hospital -- Bethke - Concord
- Mass General/North Shore Cancer Center - Danvers
- Newton-Wellesley Hospital - Newton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-07-09 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT04876599 record still lists
NCT04876599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT04876599 lists 5 locations in 1 state (Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04876599 about?
NCT04876599 is a clinical study titled "Mind-body Resiliency Intervention for Fear of Cancer Recurrence". The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.
What is the current status of trial NCT04876599?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2021-07-09. Estimated completion is 2023-08-31.
What conditions does trial NCT04876599 study?
This clinical trial studies the following conditions: Cancer, Coping Skills, Coping Behavior.
What interventions are being tested in trial NCT04876599?
The interventions under investigation include: Usual Care (BEHAVIORAL), IN FOCUS (BEHAVIORAL).
Who is sponsoring clinical trial NCT04876599?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04876599 being conducted?
This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04876599's enrollment target sits among peer trials
64 388th of 615 higher than 226 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI